The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV Article

Industry Collaboration International Collaboration

cited authors

  • Cherney, David Z., I; Cosentino, Francesco; Pratley, Richard E.; Dagogo-Jack, Samuel; Frederich, Robert; Maldonado, Mario; Liu, Jie; Pong, Annpey; Liu, Chih-Chin; Cannon, Christopher P.; VERTIS CV Investigators

authors

Publication Date

  • March 28, 2022

webpage

published in

category

keywords

  • SGLT2 inhibitor
  • cardiovascular disease
  • diabetic nephropathy
  • randomized trial
  • type 2 diabetes

start page

  • 1114

end page

  • 1122

volume

  • 24

issue

  • 6